Red flags / Dilution
HeartSciences files to sell up to $3.08 million of common stock through Maxim ATM program
HeartSciences filed a prospectus supplement dated November 19, 2026 for an at-the-market equity program with Maxim Group, allowing sales of common stock of up to $3,077,649 under the equity distribution agreement dated November 18, 2026. The company states Maxim receives a 2.5% commission while it remains subject to Form S-3 General Instruction I.B.6 limits, and that about $4.3 million was already sold under that rule in the prior 12 months. The filing also notes the non-affiliate float is $22.9 million and that a pending merger with Fortitude Mining is expected to close in Q4 2026, which can matter because ongoing dilution from share sales adds supply to the stock during a major transaction.
“In accordance with the terms of the Equity Distribution Agreement, we may offer and sell shares of our common stock having an offering price of up to $3,077,649, subject to General Instruction I.B.6 of Form S-3 and an aggregate offering price of up to $50,000,000 from time to time through Maxim, acting as our agent or principal.”
What the stock did
From the last close before the filing was public. Market cap now: $10M.
Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on HSCS
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Sep 25, 5:00 PM ET | HSCS HeartSciences Inc. | Dilution WatchForm S-3 | HeartSciences Inc. filed a new S-3 shelf registration | $10M | -9.1% | -33.6% |
| Sep 14, 4:14 PM ET | HSCS HeartSciences Inc. | Material weakness ElevatedForm 10-Q | HeartSciences says disclosure controls were not effective at July 31, 2026 due to material weaknesses | $10M | +32.2% | -6.8% |
| Sep 14, 4:14 PM ET | HSCS HeartSciences Inc. | Going concern ElevatedForm 10-Q | HeartSciences flags substantial doubt about going concern as losses and stockholders' deficit mount | $10M | +32.2% | -6.8% |